GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Price-to-Operating-Cash-Flow

YIFAN PHARMACEUTICAL CO (SZSE:002019) Price-to-Operating-Cash-Flow : 31.85 (As of May. 13, 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Price-to-Operating-Cash-Flow?

As of today (2024-05-13), YIFAN PHARMACEUTICAL CO's share price is ¥13.79. YIFAN PHARMACEUTICAL CO's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.43. Hence, YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow Ratio for today is 31.85.

The historical rank and industry rank for YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:002019' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.42   Med: 28.86   Max: 200.81
Current: 31.84

During the past 13 years, YIFAN PHARMACEUTICAL CO's highest Price-to-Operating-Cash-Flow Ratio was 200.81. The lowest was 8.42. And the median was 28.86.

SZSE:002019's Price-to-Operating-Cash-Flow is ranked worse than
72.19% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.73 vs SZSE:002019: 31.84

YIFAN PHARMACEUTICAL CO's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.15. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.43.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of YIFAN PHARMACEUTICAL CO was 6.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -31.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -24.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.30% per year.

During the past 13 years, YIFAN PHARMACEUTICAL CO's highest 3-Year average Operating Cash Flow per Share Growth Rate was 131.00% per year. The lowest was -36.40% per year. And the median was 26.85% per year.


YIFAN PHARMACEUTICAL CO Price-to-Operating-Cash-Flow Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Price-to-Operating-Cash-Flow Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.16 20.94 70.76 33.11 51.86

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.58 41.71 37.46 51.86 25.59

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow falls into.



YIFAN PHARMACEUTICAL CO Price-to-Operating-Cash-Flow Calculation

YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=13.79/0.433
=31.85

YIFAN PHARMACEUTICAL CO's Share Price of today is ¥13.79.
YIFAN PHARMACEUTICAL CO's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.43.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

YIFAN PHARMACEUTICAL CO Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines